Literature DB >> 15575917

Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation.

Ying Li1, Takaaki Koshiba, Atsushi Yoshizawa, Yukihide Yonekawa, Kosuke Masuda, Atsushi Ito, Mikiko Ueda, Takahide Mori, Hiroshi Kawamoto, Yoshimasa Tanaka, Shimon Sakaguchi, Nagahiro Minato, Kathryn J Wood, Koichi Tanaka.   

Abstract

Operational tolerance (graft acceptance in an immunosuppression (IS)-free environment) after living-donor liver transplantation (LDLT) could occur by our elective protocol in some patients. There is, nevertheless, no reliable parameter to monitor patients who may discontinue IS without a risk of rejection. To identify such parameters, we systemically phenotyped peripheral blood mononuclear cells from operationally tolerant patients. An increase was observed in the frequency of CD4+CD25high+ cells, B cells and Vdelta1/Vdelta2 gammadeltaT-cells ratio in operationally tolerant patients (Gr-tol; n = 12), compared with those from age-matched volunteers (Gr-vol; n = 24) or patients on IS (Gr-IS; n = 19). The frequency of NK cells was decreased in Gr-tol, compared with those in Gr-IS or Gr-vol. The frequency of NKT cells was decreased after LDLT, compared with that in Gr-vol. Although the contribution of those subsets to the tolerant state remains elusive, the results may provide important clues for reliable indicators of tolerance after LDLT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575917     DOI: 10.1111/j.1600-6143.2004.00611.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  63 in total

Review 1.  Regulatory immune cells in transplantation.

Authors:  Kathryn J Wood; Andrew Bushell; Joanna Hester
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

Review 2.  Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.

Authors:  Alberto Sánchez-Fueyo; Terry B Strom
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

3.  Identification of a B cell signature associated with renal transplant tolerance in humans.

Authors:  Kenneth A Newell; Adam Asare; Allan D Kirk; Trang D Gisler; Kasia Bourcier; Manikkam Suthanthiran; William J Burlingham; William H Marks; Ignacio Sanz; Robert I Lechler; Maria P Hernandez-Fuentes; Laurence A Turka; Vicki L Seyfert-Margolis
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

4.  Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.

Authors:  Marc Martínez-Llordella; Juan José Lozano; Isabel Puig-Pey; Giuseppe Orlando; Giuseppe Tisone; Jan Lerut; Carlos Benítez; Jose Antonio Pons; Pascual Parrilla; Pablo Ramírez; Miquel Bruguera; Antoni Rimola; Alberto Sánchez-Fueyo
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

5.  Marking a path to transplant tolerance.

Authors:  Vicki Seyfert-Margolis; Laurence A Turka
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 6.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 7.  Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism.

Authors:  S Yamazaki; A Kanamoto; T Takayama
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

Review 8.  Markers of acute rejection and graft acceptance in liver transplantation.

Authors:  Giacomo Germani; Kryssia Rodriguez-Castro; Francesco Paolo Russo; Marco Senzolo; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

9.  Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents.

Authors:  Josh Levitsky; Joshua Miller; Edward Wang; Anne Rosen; Cathy Flaa; Michael Abecassis; James Mathew; Anat Tambur
Journal:  Hum Immunol       Date:  2009-01-12       Impact factor: 2.850

10.  mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation.

Authors:  Roberto Gedaly; Felice De Stefano; Lilia Turcios; Marita Hill; Giovanna Hidalgo; Mihail I Mitov; Michael C Alstott; D Allan Butterfield; Hunter C Mitchell; Jeremy Hart; Ahmad Al-Attar; Chester D Jennings; Francesc Marti
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.